Advertisement

Topics

Community Acquired Pneumonia Pipeline Review, H2 2018 [Report Updated: 17072018] Prices from USD $2000

14:44 EDT 11 Aug 2018 | BioPortfolio Report Blog

Community Acquired Pneumonia Pipeline Review, H2 2018


Summary


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Community Acquired Pneumonia Pipeline Review, H2 2018, provides an overview of the Community Acquired Pneumonia Infectious Disease pipeline landscape.


Communityacquired pneumonia CAP is defined as pneumonia acquired outside a hospital or longterm care facility. Symptoms include cough, fever, shaking chills, confusion, headache and loss of appetite. Risk factors include chronic lung disease, cigarette smoking, dementia, stroke, brain injury, heart disease, liver cirrhosis and diabetes mellitus. Treatment includes antibiotics and healthy lifestyle.


Report Highlights


Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Community Acquired Pneumonia Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Community Acquired Pneumonia Infectious Disease, complete with analysis by stage of development, drug target, mechanism of action MoA, route of administration RoA and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.


The Community Acquired Pneumonia Infectious Disease pipeline guide also reviews of key players involved in therapeutic development for Community Acquired Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in PreRegistration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 5, 1, 1, 6, 2, 2 and 1 respectively.


Community Acquired Pneumonia Infectious Disease pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.


Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.


Scope


The pipeline guide provides a snapshot of the global therapeutic landscape of Community Acquired Pneumonia Infectious Disease.

The pipeline guide reviews pipeline therapeutics for Community Acquired Pneumonia Infectious Disease by companies and universities/research institutes based on information derived from company and industryspecific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from preregistration till discovery and undisclosed stages.

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, RD brief, MoA other developmental activities.

The pipeline guide reviews key companies involved in Community Acquired Pneumonia Infectious Disease therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Community Acquired Pneumonia Infectious Disease therapeutics based on mechanism of action MoA, drug target, route of administration RoA and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

The pipeline guide reviews latest news related to pipeline therapeutics for Community Acquired Pneumonia Infectious Disease


Reasons to buy


Procure strategically important competitor information, analysis, and insights to formulate effective RD strategies.

Recognize emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage.

Find and recognize significant and varied types of therapeutics under development for Community Acquired Pneumonia Infectious Disease.

Classify potential new clients or partners in the target demographic.

Develop tactical initiatives by understanding the focus areas of leading companies.

Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

Formulate corrective measures for pipeline projects by understanding Community Acquired Pneumonia Infectious Disease pipeline depth and focus of Indication therapeutics.

Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the knowhow what drove them from pipeline.

Original Article: Community Acquired Pneumonia Pipeline Review, H2 2018 [Report Updated: 17072018] Prices from USD $2000

NEXT ARTICLE

More From BioPortfolio on "Community Acquired Pneumonia Pipeline Review, H2 2018 [Report Updated: 17072018] Prices from USD $2000"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Pneumonia
Pneumonia (bronchopneumonia, lobar pneumonia and double pneumonia) is inflammation (swelling) of the tissue in one or both of your lungs. It is usually caused by an pneumococcal infection caused by bacteria called Streptococcus pneumoniae.  However,...